Paranasal Sinus Squamous Cell Carcinoma

Paranasal Sinus Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Emory University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06636734	Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial	recruiting	Phase 2	28	Emory UniversityOTHER	1	Feb 11, 2026	clinicaltrials
NCT03468218	Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer	active not recruiting	Phase 2	36	Emory UniversityOTHER	1	Jan 23, 2026	clinicaltrials